GLP-1 medications may help improve lipid profiles in some patients, though effects vary significantly based on individual metabolic factors
The TRIUMPH clinical trial program includes multiple Phase 3 studies spanning weight loss , type 2 diabetes, metabolic conditions , liver disease, and even knee osteoarthritis
Whilst emerging research suggests these drugs may have anti-inflammatory properties, there is currently no established evidence supporting their use for rheumatoid arthritis
*PLEASE NOTE: Microdosing program is available at an already discounted rate and is not available for any additional discounts
What This Transition Could Mean For Cost And Access Shifting from injectable to oral GLP-1s may improve access and adherence by simplifying storage and administration
Drink plenty of fluids to avoid dehydration (water or sports drinks, you can dilute the sports drink with water) ITS VERY IMPORTANT to hydrate at least 6-8 ounces after each loose bowel movement